img

Global Meningitis B Vaccine Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Meningitis B Vaccine Market Insights, Forecast to 2034

Japanese meningitis vaccine is a vaccine used to prevent Japanese encephalitis, and vaccination against Japanese encephalitis is an effective measure to prevent Japanese encephalitis.
Global Meningitis B Vaccine market is expected to reach to US$ 24460 million in 2024, with a positive growth of %, compared with US$ 23630 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Meningitis B Vaccine industry is evaluated to reach US$ 29030 million in 2029. The CAGR will be 2.9% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Meningitis B Vaccine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Meningitis B Vaccine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GlaxoSmithKline
Novartis
BEXSERO
TRUMENBA
Pfizer
Sanofi Pasteur Inc
Wyeth Pharmaceuticals, Inc.
Segment by Type
MenACWY (Conjugate) Vaccine
MenB (Recombinant Protein) Vaccine

Segment by Application


Hospital
Clinic

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Meningitis B Vaccine plant distribution, commercial date of Meningitis B Vaccine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Meningitis B Vaccine introduction, etc. Meningitis B Vaccine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Meningitis B Vaccine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Meningitis B Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Meningitis B Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 MenACWY (Conjugate) Vaccine
1.2.3 MenB (Recombinant Protein) Vaccine
1.3 Market by Application
1.3.1 Global Meningitis B Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Meningitis B Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Meningitis B Vaccine Revenue by Region
2.2.1 Global Meningitis B Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Meningitis B Vaccine Revenue by Region (2018-2024)
2.2.3 Global Meningitis B Vaccine Revenue by Region (2024-2029)
2.2.4 Global Meningitis B Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Meningitis B Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Meningitis B Vaccine Sales by Region
2.4.1 Global Meningitis B Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Meningitis B Vaccine Sales by Region (2018-2024)
2.4.3 Global Meningitis B Vaccine Sales by Region (2024-2029)
2.4.4 Global Meningitis B Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Meningitis B Vaccine Sales by Manufacturers
3.1.1 Global Meningitis B Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global Meningitis B Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Meningitis B Vaccine in 2022
3.2 Global Meningitis B Vaccine Revenue by Manufacturers
3.2.1 Global Meningitis B Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Meningitis B Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Meningitis B Vaccine Revenue in 2022
3.3 Global Key Players of Meningitis B Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Meningitis B Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Meningitis B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Meningitis B Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Meningitis B Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Meningitis B Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Meningitis B Vaccine Sales by Type
4.1.1 Global Meningitis B Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global Meningitis B Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Meningitis B Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Meningitis B Vaccine Revenue by Type
4.2.1 Global Meningitis B Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Meningitis B Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Meningitis B Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Meningitis B Vaccine Price by Type
4.3.1 Global Meningitis B Vaccine Price by Type (2018-2024)
4.3.2 Global Meningitis B Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Meningitis B Vaccine Sales by Application
5.1.1 Global Meningitis B Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global Meningitis B Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Meningitis B Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Meningitis B Vaccine Revenue by Application
5.2.1 Global Meningitis B Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Meningitis B Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Meningitis B Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Meningitis B Vaccine Price by Application
5.3.1 Global Meningitis B Vaccine Price by Application (2018-2024)
5.3.2 Global Meningitis B Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Meningitis B Vaccine Market Size by Type
6.1.1 US & Canada Meningitis B Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Meningitis B Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Meningitis B Vaccine Market Size by Application
6.2.1 US & Canada Meningitis B Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Meningitis B Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Meningitis B Vaccine Market Size by Country
6.3.1 US & Canada Meningitis B Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Meningitis B Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Meningitis B Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Meningitis B Vaccine Market Size by Type
7.1.1 Europe Meningitis B Vaccine Sales by Type (2018-2029)
7.1.2 Europe Meningitis B Vaccine Revenue by Type (2018-2029)
7.2 Europe Meningitis B Vaccine Market Size by Application
7.2.1 Europe Meningitis B Vaccine Sales by Application (2018-2029)
7.2.2 Europe Meningitis B Vaccine Revenue by Application (2018-2029)
7.3 Europe Meningitis B Vaccine Market Size by Country
7.3.1 Europe Meningitis B Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Meningitis B Vaccine Sales by Country (2018-2029)
7.3.3 Europe Meningitis B Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Meningitis B Vaccine Market Size
8.1.1 China Meningitis B Vaccine Sales (2018-2029)
8.1.2 China Meningitis B Vaccine Revenue (2018-2029)
8.2 China Meningitis B Vaccine Market Size by Application
8.2.1 China Meningitis B Vaccine Sales by Application (2018-2029)
8.2.2 China Meningitis B Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Meningitis B Vaccine Market Size by Type
9.1.1 Asia Meningitis B Vaccine Sales by Type (2018-2029)
9.1.2 Asia Meningitis B Vaccine Revenue by Type (2018-2029)
9.2 Asia Meningitis B Vaccine Market Size by Application
9.2.1 Asia Meningitis B Vaccine Sales by Application (2018-2029)
9.2.2 Asia Meningitis B Vaccine Revenue by Application (2018-2029)
9.3 Asia Meningitis B Vaccine Sales by Region
9.3.1 Asia Meningitis B Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Meningitis B Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Meningitis B Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Meningitis B Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Meningitis B Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Meningitis B Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Meningitis B Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Meningitis B Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Meningitis B Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Meningitis B Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Meningitis B Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Meningitis B Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Meningitis B Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Meningitis B Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 GlaxoSmithKline Meningitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline Recent Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Overview
11.2.3 Novartis Meningitis B Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Novartis Meningitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis Recent Developments
11.3 BEXSERO
11.3.1 BEXSERO Company Information
11.3.2 BEXSERO Overview
11.3.3 BEXSERO Meningitis B Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 BEXSERO Meningitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 BEXSERO Recent Developments
11.4 TRUMENBA
11.4.1 TRUMENBA Company Information
11.4.2 TRUMENBA Overview
11.4.3 TRUMENBA Meningitis B Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 TRUMENBA Meningitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 TRUMENBA Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Meningitis B Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Pfizer Meningitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Sanofi Pasteur Inc
11.6.1 Sanofi Pasteur Inc Company Information
11.6.2 Sanofi Pasteur Inc Overview
11.6.3 Sanofi Pasteur Inc Meningitis B Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Sanofi Pasteur Inc Meningitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sanofi Pasteur Inc Recent Developments
11.7 Wyeth Pharmaceuticals, Inc.
11.7.1 Wyeth Pharmaceuticals, Inc. Company Information
11.7.2 Wyeth Pharmaceuticals, Inc. Overview
11.7.3 Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Wyeth Pharmaceuticals, Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Meningitis B Vaccine Industry Chain Analysis
12.2 Meningitis B Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Meningitis B Vaccine Production Mode & Process
12.4 Meningitis B Vaccine Sales and Marketing
12.4.1 Meningitis B Vaccine Sales Channels
12.4.2 Meningitis B Vaccine Distributors
12.5 Meningitis B Vaccine Customers
13 Market Dynamics
13.1 Meningitis B Vaccine Industry Trends
13.2 Meningitis B Vaccine Market Drivers
13.3 Meningitis B Vaccine Market Challenges
13.4 Meningitis B Vaccine Market Restraints
14 Key Findings in The Global Meningitis B Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Meningitis B Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of MenACWY (Conjugate) Vaccine
Table 3. Major Manufacturers of MenB (Recombinant Protein) Vaccine
Table 4. Global Meningitis B Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Meningitis B Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Meningitis B Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Meningitis B Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Meningitis B Vaccine Revenue Market Share by Region (2018-2024)
Table 9. Global Meningitis B Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global Meningitis B Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Meningitis B Vaccine Sales by Region (2018-2024) & (K Units)
Table 12. Global Meningitis B Vaccine Sales by Region (2024-2029) & (K Units)
Table 13. Global Meningitis B Vaccine Sales Market Share by Region (2018-2024)
Table 14. Global Meningitis B Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global Meningitis B Vaccine Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Meningitis B Vaccine Sales Share by Manufacturers (2018-2024)
Table 17. Global Meningitis B Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Meningitis B Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Meningitis B Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Meningitis B Vaccine Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Meningitis B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Meningitis B Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningitis B Vaccine as of 2022)
Table 23. Global Key Manufacturers of Meningitis B Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Meningitis B Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Meningitis B Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Meningitis B Vaccine Sales by Type (2018-2024) & (K Units)
Table 28. Global Meningitis B Vaccine Sales by Type (2024-2029) & (K Units)
Table 29. Global Meningitis B Vaccine Sales Share by Type (2018-2024)
Table 30. Global Meningitis B Vaccine Sales Share by Type (2024-2029)
Table 31. Global Meningitis B Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Meningitis B Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Meningitis B Vaccine Revenue Share by Type (2018-2024)
Table 34. Global Meningitis B Vaccine Revenue Share by Type (2024-2029)
Table 35. Meningitis B Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Meningitis B Vaccine Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Meningitis B Vaccine Sales by Application (2018-2024) & (K Units)
Table 38. Global Meningitis B Vaccine Sales by Application (2024-2029) & (K Units)
Table 39. Global Meningitis B Vaccine Sales Share by Application (2018-2024)
Table 40. Global Meningitis B Vaccine Sales Share by Application (2024-2029)
Table 41. Global Meningitis B Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Meningitis B Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Meningitis B Vaccine Revenue Share by Application (2018-2024)
Table 44. Global Meningitis B Vaccine Revenue Share by Application (2024-2029)
Table 45. Meningitis B Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Meningitis B Vaccine Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Meningitis B Vaccine Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Meningitis B Vaccine Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Meningitis B Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Meningitis B Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Meningitis B Vaccine Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Meningitis B Vaccine Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Meningitis B Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Meningitis B Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Meningitis B Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Meningitis B Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Meningitis B Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Meningitis B Vaccine Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Meningitis B Vaccine Sales by Country (2024-2029) & (K Units)
Table 60. Europe Meningitis B Vaccine Sales by Type (2018-2024) & (K Units)
Table 61. Europe Meningitis B Vaccine Sales by Type (2024-2029) & (K Units)
Table 62. Europe Meningitis B Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Meningitis B Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Meningitis B Vaccine Sales by Application (2018-2024) & (K Units)
Table 65. Europe Meningitis B Vaccine Sales by Application (2024-2029) & (K Units)
Table 66. Europe Meningitis B Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Meningitis B Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Meningitis B Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Meningitis B Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Meningitis B Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Meningitis B Vaccine Sales by Country (2018-2024) & (K Units)
Table 72. Europe Meningitis B Vaccine Sales by Country (2024-2029) & (K Units)
Table 73. China Meningitis B Vaccine Sales by Type (2018-2024) & (K Units)
Table 74. China Meningitis B Vaccine Sales by Type (2024-2029) & (K Units)
Table 75. China Meningitis B Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Meningitis B Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Meningitis B Vaccine Sales by Application (2018-2024) & (K Units)
Table 78. China Meningitis B Vaccine Sales by Application (2024-2029) & (K Units)
Table 79. China Meningitis B Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Meningitis B Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Meningitis B Vaccine Sales by Type (2018-2024) & (K Units)
Table 82. Asia Meningitis B Vaccine Sales by Type (2024-2029) & (K Units)
Table 83. Asia Meningitis B Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Meningitis B Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Meningitis B Vaccine Sales by Application (2018-2024) & (K Units)
Table 86. Asia Meningitis B Vaccine Sales by Application (2024-2029) & (K Units)
Table 87. Asia Meningitis B Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Meningitis B Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Meningitis B Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Meningitis B Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Meningitis B Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Meningitis B Vaccine Sales by Region (2018-2024) & (K Units)
Table 93. Asia Meningitis B Vaccine Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Meningitis B Vaccine Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Meningitis B Vaccine Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Meningitis B Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Meningitis B Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Meningitis B Vaccine Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Meningitis B Vaccine Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Meningitis B Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Meningitis B Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Meningitis B Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Meningitis B Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Meningitis B Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Meningitis B Vaccine Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Meningitis B Vaccine Sales by Country (2024-2029) & (K Units)
Table 107. GlaxoSmithKline Company Information
Table 108. GlaxoSmithKline Description and Major Businesses
Table 109. GlaxoSmithKline Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. GlaxoSmithKline Meningitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. GlaxoSmithKline Recent Developments
Table 112. Novartis Company Information
Table 113. Novartis Description and Major Businesses
Table 114. Novartis Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Novartis Meningitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Novartis Recent Developments
Table 117. BEXSERO Company Information
Table 118. BEXSERO Description and Major Businesses
Table 119. BEXSERO Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. BEXSERO Meningitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. BEXSERO Recent Developments
Table 122. TRUMENBA Company Information
Table 123. TRUMENBA Description and Major Businesses
Table 124. TRUMENBA Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. TRUMENBA Meningitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. TRUMENBA Recent Developments
Table 127. Pfizer Company Information
Table 128. Pfizer Description and Major Businesses
Table 129. Pfizer Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Pfizer Meningitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Pfizer Recent Developments
Table 132. Sanofi Pasteur Inc Company Information
Table 133. Sanofi Pasteur Inc Description and Major Businesses
Table 134. Sanofi Pasteur Inc Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Sanofi Pasteur Inc Meningitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Sanofi Pasteur Inc Recent Developments
Table 137. Wyeth Pharmaceuticals, Inc. Company Information
Table 138. Wyeth Pharmaceuticals, Inc. Description and Major Businesses
Table 139. Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Wyeth Pharmaceuticals, Inc. Recent Developments
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Meningitis B Vaccine Distributors List
Table 145. Meningitis B Vaccine Customers List
Table 146. Meningitis B Vaccine Market Trends
Table 147. Meningitis B Vaccine Market Drivers
Table 148. Meningitis B Vaccine Market Challenges
Table 149. Meningitis B Vaccine Market Restraints
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Meningitis B Vaccine Product Picture
Figure 2. Global Meningitis B Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Meningitis B Vaccine Market Share by Type in 2022 & 2029
Figure 4. MenACWY (Conjugate) Vaccine Product Picture
Figure 5. MenB (Recombinant Protein) Vaccine Product Picture
Figure 6. Global Meningitis B Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Meningitis B Vaccine Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Meningitis B Vaccine Report Years Considered
Figure 11. Global Meningitis B Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Meningitis B Vaccine Revenue 2018-2029 (US$ Million)
Figure 13. Global Meningitis B Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Meningitis B Vaccine Revenue Market Share by Region (2018-2029)
Figure 15. Global Meningitis B Vaccine Sales 2018-2029 ((K Units)
Figure 16. Global Meningitis B Vaccine Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Meningitis B Vaccine Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Meningitis B Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Meningitis B Vaccine Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Meningitis B Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Meningitis B Vaccine Sales YoY (2018-2029) & (K Units)
Figure 22. China Meningitis B Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Meningitis B Vaccine Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Meningitis B Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Meningitis B Vaccine Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Meningitis B Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Meningitis B Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Meningitis B Vaccine in the World: Market Share by Meningitis B Vaccine Revenue in 2022
Figure 29. Global Meningitis B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Meningitis B Vaccine Sales Market Share by Type (2018-2029)
Figure 31. Global Meningitis B Vaccine Revenue Market Share by Type (2018-2029)
Figure 32. Global Meningitis B Vaccine Sales Market Share by Application (2018-2029)
Figure 33. Global Meningitis B Vaccine Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Meningitis B Vaccine Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Meningitis B Vaccine Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Meningitis B Vaccine Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Meningitis B Vaccine Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Meningitis B Vaccine Revenue Share by Country (2018-2029)
Figure 39. US & Canada Meningitis B Vaccine Sales Share by Country (2018-2029)
Figure 40. U.S. Meningitis B Vaccine Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Meningitis B Vaccine Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Meningitis B Vaccine Sales Market Share by Type (2018-2029)
Figure 43. Europe Meningitis B Vaccine Revenue Market Share by Type (2018-2029)
Figure 44. Europe Meningitis B Vaccine Sales Market Share by Application (2018-2029)
Figure 45. Europe Meningitis B Vaccine Revenue Market Share by Application (2018-2029)
Figure 46. Europe Meningitis B Vaccine Revenue Share by Country (2018-2029)
Figure 47. Europe Meningitis B Vaccine Sales Share by Country (2018-2029)
Figure 48. Germany Meningitis B Vaccine Revenue (2018-2029) & (US$ Million)
Figure 49. France Meningitis B Vaccine Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Meningitis B Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Meningitis B Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Meningitis B Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. China Meningitis B Vaccine Sales Market Share by Type (2018-2029)
Figure 54. China Meningitis B Vaccine Revenue Market Share by Type (2018-2029)
Figure 55. China Meningitis B Vaccine Sales Market Share by Application (2018-2029)
Figure 56. China Meningitis B Vaccine Revenue Market Share by Application (2018-2029)
Figure 57. Asia Meningitis B Vaccine Sales Market Share by Type (2018-2029)
Figure 58. Asia Meningitis B Vaccine Revenue Market Share by Type (2018-2029)
Figure 59. Asia Meningitis B Vaccine Sales Market Share by Application (2018-2029)
Figure 60. Asia Meningitis B Vaccine Revenue Market Share by Application (2018-2029)
Figure 61. Asia Meningitis B Vaccine Revenue Share by Region (2018-2029)
Figure 62. Asia Meningitis B Vaccine Sales Share by Region (2018-2029)
Figure 63. Japan Meningitis B Vaccine Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Meningitis B Vaccine Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Meningitis B Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Meningitis B Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. India Meningitis B Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Meningitis B Vaccine Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Meningitis B Vaccine Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Meningitis B Vaccine Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Meningitis B Vaccine Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Meningitis B Vaccine Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Meningitis B Vaccine Sales Share by Country (2018-2029)
Figure 74. Brazil Meningitis B Vaccine Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Meningitis B Vaccine Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Meningitis B Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Meningitis B Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Meningitis B Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. Meningitis B Vaccine Value Chain
Figure 80. Meningitis B Vaccine Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries